• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Transcarotid transcatheter aortic valve implantation with a novel balloon expandable Myval THV under the local anesthesia.

作者信息

Ayhan Hüseyin, Karaduman Bilge Duran, Keleş Telat, Uğuz Emrah, Boysan Emre, Bozkurt Engin

机构信息

Department of Cardiology, Medicana International Ankara Hospital, Atilim University, Ankara, Turkey.

Department of Cardiology, Ankara City Hospital, Ankara Yıldırım Beyazıt University, Ankara, Turkey.

出版信息

J Geriatr Cardiol. 2022 Jul 28;19(7):562-564. doi: 10.11909/j.issn.1671-5411.2022.07.006.

DOI:10.11909/j.issn.1671-5411.2022.07.006
PMID:35975016
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9361163/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88ec/9361163/82f017ad8955/jgc-19-7-562-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88ec/9361163/0c53fb633bd4/jgc-19-7-562-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88ec/9361163/b9b68b1f6775/jgc-19-7-562-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88ec/9361163/82f017ad8955/jgc-19-7-562-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88ec/9361163/0c53fb633bd4/jgc-19-7-562-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88ec/9361163/b9b68b1f6775/jgc-19-7-562-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88ec/9361163/82f017ad8955/jgc-19-7-562-3.jpg

相似文献

1
Transcarotid transcatheter aortic valve implantation with a novel balloon expandable Myval THV under the local anesthesia.在局部麻醉下使用新型球囊扩张式Myval经导管主动脉瓣在经颈动脉途径进行经导管主动脉瓣植入术。
J Geriatr Cardiol. 2022 Jul 28;19(7):562-564. doi: 10.11909/j.issn.1671-5411.2022.07.006.
2
Clinical Comparison of a Novel Balloon-Expandable Versus a Self-Expanding Transcatheter Heart Valve for the Treatment of Patients with Severe Aortic Valve Stenosis: The EVAL Registry.新型球囊扩张式与自膨胀式经导管心脏瓣膜治疗重度主动脉瓣狭窄患者的临床比较：EVAL注册研究
J Clin Med. 2022 Feb 12;11(4):959. doi: 10.3390/jcm11040959.
3
Quantitative Angiographic Assessment of Aortic Regurgitation after Transcatheter Aortic Valve Implantation among Three Balloon-Expandable Valves.三种球囊扩张式经导管主动脉瓣置换术后主动脉瓣反流的定量血管造影评估。
Glob Heart. 2021 Mar 19;16(1):20. doi: 10.5334/gh.959.
4
Performance of balloon-expandable transcatheter bioprostheses in inoperable patients with pure aortic regurgitation of a native valve: The BE-PANTHEON international project.球囊扩张式经导管生物瓣膜在无法手术的原发性单纯主动脉瓣反流患者中的应用：BE-PANTHEON国际项目。
Cardiovasc Revasc Med. 2025 May;74:28-33. doi: 10.1016/j.carrev.2024.08.007. Epub 2024 Aug 22.
5
Transcatheter valve-in-valve or valve-in-ring implantation with a novel balloon-expandable device in patients with bioprosthetic left side heart valves failure: 1-year follow-up from a multicenter experience.经导管瓣中瓣或瓣中环植入新型球囊扩张装置治疗生物瓣左心瓣膜功能障碍患者：一项多中心经验的1年随访
Int J Cardiol. 2023 Apr 1;376:35-45. doi: 10.1016/j.ijcard.2023.01.017. Epub 2023 Jan 16.
6
Comparing two-year outcomes of balloon-expandable Myval and self-expanding Evolut R in severe aortic valve stenosis.比较球囊扩张式 Myval 和自膨式 Evolut R 在重度主动脉瓣狭窄中的两年疗效。
Int J Cardiol. 2024 Apr 1;400:131701. doi: 10.1016/j.ijcard.2023.131701. Epub 2023 Dec 31.
7
LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial. landmark 比较新一代 Myval 经导管心脏瓣膜系列与同期瓣膜（Sapien 和 Evolut）在真实世界中患有严重症状性原发性主动脉瓣狭窄的个体中的早期结果：一项随机非劣效性试验。
Lancet. 2024 Jun 22;403(10445):2695-2708. doi: 10.1016/S0140-6736(24)00821-3. Epub 2024 May 22.
8
Myval: A Novel Transcatheter Heart Valve for the Treatment of Severe Aortic Stenosis.Myval：一种用于治疗严重主动脉瓣狭窄的新型经导管心脏瓣膜。
Interv Cardiol. 2023 Apr 10;18:e12. doi: 10.15420/icr.2020.32. eCollection 2023.
9
Early clinical and haemodynamic matched comparison of balloon-expandable valves.球囊扩张瓣膜的早期临床和血液动力学匹配比较。
Heart. 2022 May;108(9):725-732. doi: 10.1136/heartjnl-2021-319349. Epub 2021 Jul 20.
10
A novel balloon-expandable transcatheter aortic valve bioprosthesis: Myval and Myval Octacor.一种新型球囊扩张式经导管主动脉瓣生物假体：Myval 和 Myval Octacor。
Expert Rev Cardiovasc Ther. 2024 Jul;22(7):325-337. doi: 10.1080/14779072.2024.2375345. Epub 2024 Jul 15.

本文引用的文献

1
Transcatheter aortic valve implantation via the left axillary artery route in a patient with a permanent pacemaker: The first transaxillary artery route experience with a Meril's MyvalTM transaortic valve in Turkey.经左腋动脉途径为植入永久起搏器的患者行经导管主动脉瓣植入术：土耳其首例使用Meril公司MyvalTM经主动脉瓣膜经腋动脉途径的经验。
Anatol J Cardiol. 2021 Jul;25(7):517-519. doi: 10.5152/AnatolJCardiol.2021.54857.
2
ACURATE neo™ aortic valve implantation via carotid artery access: first case report.经颈动脉入路行 ACURATE neo™ 主动脉瓣植入术：首例病例报告。
J Cardiothorac Surg. 2021 Jun 4;16(1):160. doi: 10.1186/s13019-021-01544-5.
3
Carotid access for transcatheter aortic valve replacement: A meta-analysis.
经导管主动脉瓣置换术的颈动脉入路：荟萃分析。
Catheter Cardiovasc Interv. 2021 Mar;97(4):723-733. doi: 10.1002/ccd.29244. Epub 2020 Sep 5.
4
Evaluation of procedural and clinical outcomes of transcatheter aortic valve implantation: A single-center experience.经导管主动脉瓣植入术的程序和临床结果评估：单中心经验。
Anatol J Cardiol. 2020 Apr;23(5):288-296. doi: 10.14744/AnatolJCardiol.2020.03942.
5
Alternate Access for TAVI: Stay Clear of the Chest.经导管主动脉瓣植入术的替代入路：避开胸部。
Interv Cardiol. 2018 Sep;13(3):145-150. doi: 10.15420/icr.2018.22.1.
6
Temporal Trends in Transcatheter Aortic Valve Replacement in France: FRANCE 2 to FRANCE TAVI.法国经导管主动脉瓣置换术的时间趋势：FRANCE 2 至 FRANCE TAVI。
J Am Coll Cardiol. 2017 Jul 4;70(1):42-55. doi: 10.1016/j.jacc.2017.04.053.
7
Comparison 30-day clinical complications between transfemoral versus transapical aortic valve replacement for aortic stenosis: a meta-analysis review.经股动脉与经心尖主动脉瓣置换术治疗主动脉瓣狭窄的30天临床并发症比较：一项荟萃分析综述
J Cardiothorac Surg. 2013 Jul 3;8:168. doi: 10.1186/1749-8090-8-168.